Back to search

United Kingdom· GB-APID-4001111000001102

Hyalase 1500unit powder for solution for injection ampoules

A hyaluronidase product containing hyaluronidase, registered in United Kingdom by Wockhardt UK Ltd. The same ATC class is registered in 7 of our 19 countries.

ATC B06AA03

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedHyalase 1500unit powder for solution …ATCB06AA03REGISTER NO.GB-APID-4001111000001…PACKS LISTED1CHECKEDSeptember 13, 2026

Where it is registered

Hyaluronidase is registered in 7 of 19 countries.

Countries holding a registration under ATC B06AA03 (hyaluronidase), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 3 of them publish a price we can compare per daily dose

Hyaluronidase · ATC B06AA03

7 / 19 countries

  • Finlandprice
  • Germany
  • Ireland
  • Netherlands
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Hyaluronidase
Manufacturer
Wockhardt UK Ltd
Country
United Kingdom (GB)
ATC code
B06AA03
ATC class
Hyaluronidase
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5012727742922

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

84 interactions on record for hyaluronidase.

Graded by severity as the source publishes them — 84 minor. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Hyaluronidase · interactions on record

84 records

Interaction register. Grades as the source publishes them.

Same medicine, other countries

Hyaluronidase in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All hyaluronidase products

Authorised across Europe · EMA

The same active substance is authorised in 5 EEA countries. Names it is sold under:

  • Austria · Hylase Dessau
  • Germany · Hylase Dessau
  • Ireland · Hyaluronidase Pinewood Laboratories
  • Malta · Hyalase
  • Netherlands · Hyason

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6ab9f1ce-190f-47cb-ac91-efb17571748a
GET /v1/drugs/6ab9f1ce-190f-47cb-ac91-efb17571748a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "4001111000001102",
  "desc": "Hyalase 1500unit powder for solution for injection ampoules (Wockhardt UK Ltd)",
  "form": "Powder for solution for injection",
  "vpid": "41878311000001106",
  "source": "dmd",
  "vtm_id": "776218001",
  "strength": "1500 unit",
  "substance": "Hyaluronidase",
  "ingredient": "Hyaluronidase",
  "supplier_code": "9301611000001105"
}

See everything about hyaluronidase.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.